According to our (Global Info Research) latest study, the global Perfluorocarbon Liquid for Ophthalmic Surgery market size was valued at US$ 127 million in 2025 and is forecast to a readjusted size of US$ 189 million by 2032 with a CAGR of 6.0% during review period.
In 2025, global Perfluorocarbon Liquid for Ophthalmic Surgery production reached approximately 760 k units, with an average global market price of around US$162 per unit. Perfluorocarbon Liquids (PFCLs) are clear, synthetic, and exceptionally dense liquids used as intraoperative tools in complex vitreoretinal surgeries (such as severe retinal detachments). Because they are heavier than water, surgeons inject them into the eye to mechanically flatten the retina and displace fluid away from retinal tears.
The global market for ophthalmic perfluorocarbon liquids (PFCLs) is anchored in irreversible demographic shifts. The rising incidence of retinal detachment and diabetic retinopathy among aging populations continues to drive vitrectomy surgical volumes, underpinning steady demand for PFCLs as essential intraoperative tamponade agents.
On the product front, first-generation formulations based on perfluorodecalin have accumulated extensive clinical experience globally, yet inherent limitations in purity and concerns over postoperative residual toxicity constrain their utility. Second-generation products featuring high-purity perfluorooctane demonstrate meaningful improvements in safety, lower residue, and reduced viscosity, positioning them as the core direction for clinical upgrade, with regulatory approvals already secured from China‘s NMPA.
The regulatory landscape is tightening competitive barriers. PFCLs are uniformly classified as Class III high-risk medical devices across major markets, subject to rigorous premarket approval and lifecycle quality management requirements. The EU REACH regulation imposes additional compliance obligations on fluorinated chemicals. Within China, the expansion of government-led volume-based procurement and policies favoring domestically manufactured products in public procurement create structural openings for local players, while upstream fluorocarbon raw material production capacity is simultaneously scaling up to strengthen supply chain autonomy. The market will continue to evolve along two principal trajectories, product-level technological upgrading and regional structural substitution, with a clear long-term direction.
This report is a detailed and comprehensive analysis for global Perfluorocarbon Liquid for Ophthalmic Surgery market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Perfluorocarbon Liquid for Ophthalmic Surgery market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Perfluorocarbon Liquid for Ophthalmic Surgery market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Perfluorocarbon Liquid for Ophthalmic Surgery market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Perfluorocarbon Liquid for Ophthalmic Surgery market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Perfluorocarbon Liquid for Ophthalmic Surgery
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Perfluorocarbon Liquid for Ophthalmic Surgery market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alcon, Bausch + Lomb, BVI Medical, Geuder AG, DORC (ZEISS), Alchimia srl, Pharmpur, Toomac Ophthalmic, Micromed srl, Biotech Healthcare Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Perfluorocarbon Liquid for Ophthalmic Surgery market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Perfluorooctane
Perfluorodecalin
Market segment by Specification
5 ml/unit
7 ml/unit
Market segment by Package
Sterile Vials
Pre-filled Syringes
Market segment by Application
Hospital
Ophthalmology Clinic
Major players covered
Alcon
Bausch + Lomb
BVI Medical
Geuder AG
DORC (ZEISS)
Alchimia srl
Pharmpur
Toomac Ophthalmic
Micromed srl
Biotech Healthcare Group
Shanghai Jieshi Medical Technology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Perfluorocarbon Liquid for Ophthalmic Surgery product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Perfluorocarbon Liquid for Ophthalmic Surgery, with price, sales quantity, revenue, and global market share of Perfluorocarbon Liquid for Ophthalmic Surgery from 2021 to 2026.
Chapter 3, the Perfluorocarbon Liquid for Ophthalmic Surgery competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Perfluorocarbon Liquid for Ophthalmic Surgery breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Perfluorocarbon Liquid for Ophthalmic Surgery market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Perfluorocarbon Liquid for Ophthalmic Surgery.
Chapter 14 and 15, to describe Perfluorocarbon Liquid for Ophthalmic Surgery sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Perfluorocarbon Liquid for Ophthalmic Surgery. Industry analysis & Market Report on Perfluorocarbon Liquid for Ophthalmic Surgery is a syndicated market report, published as Global Perfluorocarbon Liquid for Ophthalmic Surgery Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Perfluorocarbon Liquid for Ophthalmic Surgery market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.